|
Showing 1 - 5 of
5 matches in All Departments
The Classic Edition of this foundational text includes a new
preface from Holly A. Tuokko, examining how the field of Mild
Cognitive Impairment (MCI) has developed since first publication.
Bringing together research from multiple studies and perspectives
from various countries, the volume identifies MCI as an important
clinical transition between normal aging and the early stages of
Alzheimer's disease (AD). The up-to-date preface highlights the
expansion in research, examining the benefits of various
pharmacological, cognitive and behavioral approaches to
intervention. Influenced by recent findings in neuroplasticity
across the lifespan, the book recognizes the importance of
intervention at the earliest stages of the decline trajectory. It
revisits the contested diagnostic approaches for MCI as well as the
varying prevalence of MCI internationally, yet points to the need
for further longitudinal studies to fully understand the condition.
Mild Cognitive Impairment continues to provide a comprehensive
resource for clinicians, researchers and students involved in the
study, diagnosis, treatment and rehabilitation of people with MCI.
The Classic Edition of this foundational text includes a new
preface from Holly A. Tuokko, examining how the field of Mild
Cognitive Impairment (MCI) has developed since first publication.
Bringing together research from multiple studies and perspectives
from various countries, the volume identifies MCI as an important
clinical transition between normal aging and the early stages of
Alzheimer's disease (AD). The up-to-date preface highlights the
expansion in research, examining the benefits of various
pharmacological, cognitive and behavioral approaches to
intervention. Influenced by recent findings in neuroplasticity
across the lifespan, the book recognizes the importance of
intervention at the earliest stages of the decline trajectory. It
revisits the contested diagnostic approaches for MCI as well as the
varying prevalence of MCI internationally, yet points to the need
for further longitudinal studies to fully understand the condition.
Mild Cognitive Impairment continues to provide a comprehensive
resource for clinicians, researchers and students involved in the
study, diagnosis, treatment and rehabilitation of people with MCI.
Mild Cognitive Impairment (MCI) has been identified as an important
clinical transition between normal aging and the early stages of
Alzheimer's disease (AD). Since treatments for AD are most likely
to be most effective early in the course of the disease, MCI has
become a topic of great importance and has been investigated in
different populations of interest in many countries. This book
brings together these differing perspectives on MCI for the first
time. This volume provides a comprehensive resource for clinicians,
researchers, and students involved in the study, diagnosis,
treatment, and rehabilitation of people with MCI. Clinical
investigators initially defined mild cognitive impairment (MCI) as
a transitional condition between normal aging and the early stages
of Alzheimer's disease (AD). Because the prevalence of AD increases
with age and very large numbers of older adults are affected
worldwide, these clinicians saw a pressing need to identify AD as
early as possible. It is at this very early stage in the disease
course that treatments to slow the progress and control symptoms
are likely to be most effective. Since the first introduction of
MCI, research interest has grown exponentially, and the utility of
the concept has been investigated from a variety of perspectives in
different populations of interest (e.g., clinical samples,
volunteers, population-based screening) in many different
countries. Much variability in findings has resulted. Although it
has been acknowledged that the differences observed between samples
may be 'legitimate variations', there has been no attempt to
understand what it is we have learned about MCI (i.e., common
features and differences) from each of these perspectives. This
book brings together information about MCI in different populations
from around the world. Mild Cognitive Impairment will be an
important resource for any clinician, researcher, or student
involved in the study, detection, treatment, and rehabilitation of
people with MCI.
Mild Cognitive Impairment (MCI) has been identified as an important
clinical transition between normal aging and the early stages of
Alzheimer's disease (AD). Since treatments for AD are most likely
to be most effective early in the course of the disease, MCI has
become a topic of great importance and has been investigated in
different populations of interest in many countries. This book
brings together these differing perspectives on MCI for the first
time. This volume provides a comprehensive resource for clinicians,
researchers, and students involved in the study, diagnosis,
treatment, and rehabilitation of people with MCI. Clinical
investigators initially defined mild cognitive impairment (MCI) as
a transitional condition between normal aging and the early stages
of Alzheimer's disease (AD). Because the prevalence of AD increases
with age and very large numbers of older adults are affected
worldwide, these clinicians saw a pressing need to identify AD as
early as possible. It is at this very early stage in the disease
course that treatments to slow the progress and control symptoms
are likely to be most effective. Since the first introduction of
MCI, research interest has grown exponentially, and the utility of
the concept has been investigated from a variety of perspectives in
different populations of interest (e.g., clinical samples,
volunteers, population-based screening) in many different
countries. Much variability in findings has resulted. Although it
has been acknowledged that the differences observed between samples
may be 'legitimate variations', there has been no attempt to
understand what it is we have learned about MCI (i.e., common
features and differences) from each of these perspectives. This
book brings together information about MCI in different populations
from around the world. Mild Cognitive Impairment will be an
important resource for any clinician, researcher, or student
involved in the study, detection, treatment, and rehabilitation of
people with MCI.
Presenting best practices for assessment and intervention with
older adults experiencing cognitive decline, this book draws on
cutting-edge research and extensive clinical experience. The
authors' integrative approach skillfully interweaves
neuropsychological and developmental knowledge. The volume provides
guidelines for evaluating and differentiating among normal aging,
subjective cognitive decline, mild cognitive impairment, and
different types of dementia. It identifies risk and protective
factors that may influence an individual's trajectory and describes
how to create a sound case conceptualization. Evidence-based
strategies for pharmacological, cognitive, behavioral, and
psychological intervention with patients and their caregivers are
illustrated with vivid case examples.
|
You may like...
Barbie
Margot Robbie, Ryan Gosling
Blu-ray disc
R266
Discovery Miles 2 660
|